HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cilene Rebouças de Lima Selected Research

111In-DTPA-trastuzumab

1/2021Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cilene Rebouças de Lima Research Topics

Disease

1Neoplasms (Cancer)
01/2021
1Fibroadenoma
07/2012

Drug/Important Bio-Agent (IBA)

11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021
1human ERBB2 proteinIBA
01/2021
1111In-DTPA-trastuzumabIBA
01/2021
1Chelating AgentsIBA
01/2021
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1Proteoglycans (Proteoglycan)IBA
07/2012
1DecorinIBA
07/2012
1Glucuronic Acid (Glucuronate)IBA
07/2012
1GlycosaminoglycansIBA
07/2012
1Versicans (Versican)IBA
07/2012